Association between U.S. State AIDS Drug Assistance Program (ADAP) Features and HIV Antiretroviral Therapy Initiation, 2001–2009

David B Hanna, Kate Buchacz, Kelly A Gebo, Nancy A Hessol, Michael A Horberg, Lisa P Jacobson, Gregory D Kirk, Mari M Kitahata, P Todd Korthuis, Richard D Moore, Sonia Napravnik, Pragna Patel, Michael J Silverberg, Timothy R Sterling, James H Willig, Ann Collier, Hasina Samji, Jennifer E Thorne, Keri N Althoff, Jeffrey N Martin, Benigno Rodriguez, Elizabeth A Stuart, Stephen J Gange and for the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA)

PLOS ONE, 2013, vol. 8, issue 11, 1-11

Abstract: Background: U.S. state AIDS Drug Assistance Programs (ADAPs) are federally funded to provide antiretroviral therapy (ART) as the payer of last resort to eligible persons with HIV infection. States differ regarding their financial contributions to and ways of implementing these programs, and it remains unclear how this interstate variability affects HIV treatment outcomes. Methods: We analyzed data from HIV-infected individuals who were clinically-eligible for ART between 2001 and 2009 (i.e., a first reported CD4+

Date: 2013
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0078952 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 78952&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0078952

DOI: 10.1371/journal.pone.0078952

Access Statistics for this article

More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().